Tuesday, June 18, 2019

George Pentheroudakis

MD Associate Professor of Oncology, Department of Medical Oncology, Medical School, University of Ioannina

George Pentheroudakis
George Pentheroudakis

George Pentheroudakis holds an MD degree from the Aristotle University of Thessaloniki and a PhD degree from the University of Ioannina, Greece. He specialised in Internal Medicine in Thessaloniki, Greece (1993-1999), subsequently held a National Training Number in Medical Oncology at the Beatson Oncology Centre, Glasgow, United Kingdom (1999-2002). He currently serves as Associate Professor of Oncology at the Medical School, University of Ioannina, Greece, where he is the Head of the Medical Oncology Department. He served as Scientific Committee Chair of the Hellenic Cooperative Oncology Group (HeCOG), and is the Coordinator of the HeCOG Gastrointestinal Working Group.

He is actively involved in translational research and phase I-II studies evaluating novel agents targeting membrane receptors, cell signalling pathways, immune response and angiogenesis. HeCOG, the group he participates in, is active in the development of therapeutic approaches with the purpose of developing personalised therapies and predictive biomarkers, essentially by running a large annotated tissue bank and a greek clinical trial network of 15 centers. His main research interests are gastrointestinal cancer, cancer of unknown primary, neuroendocrine tumours and pharmacokinetic studies in phase I trials of new antineoplastic compounds.

Dr. Pentheroudakis served as co chair (2012-2014) and currently as Chair of the ESMO Guidelines Committee and is a member of the Executive Board of the European Society for Medical Oncology (ESMO, 2016-2017) and the ESMO CUP and Endocrine Tumour Faculty.

He is also member of the American Society of Clinical Oncology (ASCO) and is actively involved in different editorial boards including Cancers, Cancer Treatment Communications, EJSO - European Journal of Surgical Oncology, Rare Cancers and Therapy. He has (co)authored 237 PubMed-indexed peer-reviewed papers and speaks English, French and Italian.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).
Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.
Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.

© 2019 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team